Covid-19 Group 2 patients neutralising monoclonal antibodies and antivirals for patients with hospital-onset COVID-19 (976)
Warning
A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments.
Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient
characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to
adverse drug reactions in patients with multiple morbidities or frailty.
If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to
record these and communicate them to others involved in the care of the patient.